Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

CUSIP: 03168L105

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Class A Common Stock, par value $0.01
Shares outstanding
315,976,000
Total 13F shares
99,933,342
Share change
-1,638,066
Total reported value
$511,565,477
Put/Call ratio
118%
Price per share
$5.12
Number of holders
153
Value change
-$13,076,955
Number of buys
77
Number of sells
73

Quarterly Holders Quick Answers

What is CUSIP 03168L105?
CUSIP 03168L105 identifies AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q2 2021

As of 30 Jun 2021, Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by 153 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 99,933,342 shares. The largest 10 holders included Fosun International Ltd, TPG Group Holdings (SBS) Advisors, Inc., VANGUARD GROUP INC, BlackRock Inc., Eversept Partners, LP, Neuberger Berman Group LLC, STATE STREET CORP, Nuveen Asset Management, LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, and VICTORY CAPITAL MANAGEMENT INC. This page lists 153 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.